维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Harmsze"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	CYP2C19 * 2 and CYP2C9 * 3 alleles are associated with stent thrombosis: a case -control study显示文摘	Harmsze AM van Werkum JW Ten Berg JM	2010	Eur Heart J2010，31，24：	1
2	Besides CYP2CI92, the variant allele CYP2C93 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation显示文摘	Harmsze A van Werkum J W Bouman H J	2010	Pharmacogenet Genomics2010，20，1：	1
3	The use of amlodipine,but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response显示文摘	Harmsze AM Robijns K van Werkum JW		0，，05：	1
4	Variability in on-treatment platelet reactivity explained by CYP2CI9*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting显示文摘	Bouman H J Harmsze A M van Werkum J W	2011	Heart2011，97，15：	1
5	CYP2C19* 2 and CYP2C9* 3 alleles are associated with stent thrombosis: a case-control study显示文摘	Harmsze AM van Werkum JW Ten Berg JM	2010	Eur Heart J2010，31，：	1
6	Besides CYP2C19* 2, the variant allele CYP2C9* 3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation 显示文摘	Harmsze A van Werkum JW Bouman HI	2010	Pharmacogenet Genomics2010，20，：	1
7	CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel 显示文摘	Peters Harmsze ten Berg	2011	Pharmacogenomics2011，12，2：	1
8	CYP2C192 and CYP2C93 alleles are associated with stent thrombosis:a case-control study显示文摘	Harmsze AM Van Werkum JW Ten Berg JM	2010	Eur Heart J2010，31，24：	1
9	CYP2C19and ABCB1 genes and individualized treatment with clopi-dogrel显示文摘	Peters BJ Harmsze AM ten Berg JM	2011	Pharmacogenomics2011，12，2：	1
10	The use ofamlodipine,but not of P - glycoprotein inhibiting calciumchannel blockers is associated with clopidogrel poor - re-sponse 显示文摘	Harmsze AM Robijns K van Werkum JW	2010	Thromb Haemost2010，103，5：	1
11	The use of the Verify Now system to monitor antiplatelet therapy, a review of the current evidence 显示文摘	VANWERKUM J W HARMSZE A M ELSENBERG E H	2008	Platelets2008，19，7：	1
12	CYP2C19 ± 2 and CYP2C9 ± 3 alleles are associated with stent thrombosis: a case-control study显示文摘	Harmsze AM van Werkum JW Ten Berg JM	2010	Eur Heart J2010，31，24：	1
13	CYP2C19 * 2 and CYP2C9 * 3 alleles are associated with stent thrombosis: a case-control study显示文摘	Harmsze AM van Werkum JW Ten Berg JM	2010	Eur Heart J2010，31，24：	1
14	The influence of CYP2C19 * 2 and * 17 on on-treatment platelet reactivity and bleed- ing events in patients undergoing elective coronary stenting显示文摘	Harmsze AM van Werkum JW Hackeng CM	2012	Phar- maeogenet Genomics2012，22，3：	1
15	The use of amlodipine,but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response显示文摘	HARMSZE A M ROBIJNS K VAN WERKUM JW	2010	Thromb Haemost2010，103，5：	1
16	Besides CYP2C192,the variant allele CYP2C93 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation显示文摘	Harmsze A van WJW Bouman HJ	2010	Pharmacogenet Genomics2010，20，1：	1
17	Besides CYP2C19 * 2, the variant allele CYP2C9 * 3 is associated with higher on clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation 显示文摘	Harmsze A van Werkum JW Bouman HJ	2010	Pharmacogenet Genomics2010，20，：	1
18	The influence of CYP2CI9 * 2 and * 17 on on - treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting 显示文摘	Harmsze AM van Werkum JW Hackeng CM	2012	Pharmacogenet Genomics2012，22，：	1
19	Combined influence of proton -pump inhibitors, calcium -channel blockers and CYP2C19*2 on on -treatment platelet reactivity and on the occurrence of atherothrom-botic events after percutaneous coronary intervention显示文摘	Harmsze AM van Werkum JW Souverein PC	2011	J Thromb Haemost2011，9，10：	1
20	Varia hility in on-treatment platelet reactivity explained by CYP2C19* 2 genotype is modest in clopidogrel pretreated patients under going coronary stenting显示文摘	BOUMAN H J HARMSZE A M VAN WERKUM J W	2011	Heart2011，97，15：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示